Medtronic Cardiovascular is the lead sponsor of 17 current clinical trials in our USA, UK, China and Ireland registers. 7 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is AAA - Abdominal Aortic Aneurysm.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Harmony TPV EMEA PMS
NCT06906926 · ClinicalTrials.gov ↗ · Severe Pulmonary Valve Regurgitation
|
Not applicable | Recruiting | 2025-07 | Ireland |
|
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
NCT05496998 · ClinicalTrials.gov ↗ · Mitral Regurgitation
|
Not applicable | Recruiting | 2023-02 | UK |
|
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347 · ClinicalTrials.gov ↗ · Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
|
Not applicable | Recruiting | 2023-01 | UK, USA, China |
|
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
NCT07321899 · ClinicalTrials.gov ↗ · Severe Tricuspid Regurgitation
|
Not applicable | Recruiting | 2026-09 | USA |
|
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)
NCT07754318 · ClinicalTrials.gov ↗ · AAA - Abdominal Aortic Aneurysm
|
Not applicable | Recruiting | 2026-08 | China |
|
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
NCT03242642 · ClinicalTrials.gov ↗ · Mitral Valve Regurgitation
|
Not applicable | Recruiting | 2017-10 | USA |
|
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
NCT06777368 · ClinicalTrials.gov ↗ · Aortic Stenosis
|
Observational | Recruiting | 2025-02 | USA |
|
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755 · Moderate Aortic Valve Stenosis
|
Not applicable | Active, closed | 2022-04 | Ireland, UK, USA |
|
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252 · AAA - Abdominal Aortic Aneurysm
|
Observational | Active, closed | 2017-10 | UK |
|
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
NCT02701283 · Aortic Valve Stenosis
|
Not applicable | Active, closed | 2016-03 | USA |
|
Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System
NCT02322840 · Mitral Valve Insufficiency
|
Not applicable | Active, closed | 2015-04 | UK, USA |
|
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
NCT01586910 · ClinicalTrials.gov ↗ · Severe Aortic Stenosis
|
Not applicable | Active, closed | 2012-04 | UK, USA |
|
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
NCT04722250 · ClinicalTrials.gov ↗ · Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement
|
Not applicable | Active, closed | 2021-04 | UK, USA |
|
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
NCT03635424 · ClinicalTrials.gov ↗ · Bicuspid Aortic Valve
|
Not applicable | Active, closed | 2018-10 | USA |
|
TTVR Early Feasibility Study
NCT04433065 · ClinicalTrials.gov ↗ · Tricuspid Regurgitation
|
Not applicable | Active, closed | 2020-10 | USA |
|
Harmony TPV Post-Approval Study
NCT05077774 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Tetrology of Fallot, RVOT Anomaly
|
Not applicable | Active, closed | 2021-10 | USA |
|
Evolut PRO China Clinical Study
NCT04982588 · ClinicalTrials.gov ↗ · Severe, Symptomatic Aortic Stenosis
|
Not applicable | Active, closed | 2021-07 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 12 | 4 |
| Clinical trials in UK | 7 | 2 |
| Clinical trials in China | 3 | 2 |
| Clinical trials in Ireland | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Endologix | 1 |
Sponsors with the most current trials registered for this condition.
Medtronic Cardiovascular is the lead sponsor of 17 current trials on ClinicalTrials.gov in our USA, UK, China and Ireland registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 7 of its 17 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.